Garg V - Search Results

1

Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritis.

Murray E, Ellis A, Butylkova Y, Skup M, Kalabic J, Garg V. Murray E, et al. Among authors: garg v. J Comp Eff Res. 2018 Oct;7(10):959-974. doi: 10.2217/cer-2017-0106. Epub 2018 Aug 21. J Comp Eff Res. 2018. PMID: 30129776 Free article.

2

Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany.

Li N, Betts KA, Messali AJ, Skup M, Garg V. Li N, et al. Among authors: garg v. Clin Ther. 2017 Aug;39(8):1618-1627. doi: 10.1016/j.clinthera.2017.06.009. Epub 2017 Jul 17. Clin Ther. 2017. PMID: 28729087 Free article.

3

Kaeley GS, MacCarter DK, Goyal JR, Liu S, Chen K, Griffith J, Kupper H, Garg V, Kalabic J. Kaeley GS, et al. Among authors: garg v. Rheumatol Ther. 2018 Jun;5(1):123-134. doi: 10.1007/s40744-018-0105-7. Epub 2018 Mar 24. Rheumatol Ther. 2018. PMID: 29574622 Free PMC article.

4

Economic Impact of Non-Medical Switching from Originator Biologics to Biosimilars: A Systematic Literature Review.

Liu Y, Yang M, Garg V, Wu EQ, Wang J, Skup M. Liu Y, et al. Among authors: garg v. Adv Ther. 2019 Aug;36(8):1851-1877. doi: 10.1007/s12325-019-00998-3. Epub 2019 Jun 5. Adv Ther. 2019. PMID: 31168766 Free PMC article.

5

Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study.

Van den Bosch F, Ostor AJK, Wassenberg S, Chen N, Wang C, Garg V, Kalabic J. Van den Bosch F, et al. Among authors: garg v. Rheumatol Ther. 2017 Jun;4(1):85-96. doi: 10.1007/s40744-017-0061-7. Epub 2017 Mar 30. Rheumatol Ther. 2017. PMID: 28361468 Free PMC article.

6

Erratum to: Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study.

Van den Bosch F, Ostor AJK, Wassenberg S, Chen N, Wang C, Garg V, Kalabic J. Van den Bosch F, et al. Among authors: garg v. Rheumatol Ther. 2017 Jun;4(1):97. doi: 10.1007/s40744-017-0065-3. Rheumatol Ther. 2017. PMID: 28474206 Free PMC article. No abstract available.

7

Is Patient Support Program Participation Associated with Longer Persistence and Improved Adherence Among New Users of Adalimumab? A Retrospective Cohort Study.

Srulovici E, Garg V, Ghilai A, Feldman B, Hoshen M, Balicer RD, Skup M, Leventer-Roberts M. Srulovici E, et al. Among authors: garg v. Adv Ther. 2018 May;35(5):655-665. doi: 10.1007/s12325-018-0706-0. Epub 2018 May 10. Adv Ther. 2018. PMID: 29748914

8

Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study.

Aletaha D, Epstein AJ, Skup M, Zueger P, Garg V, Panaccione R. Aletaha D, et al. Among authors: garg v. Adv Ther. 2019 Jul;36(7):1672-1683. doi: 10.1007/s12325-019-00964-z. Epub 2019 May 17. Adv Ther. 2019. PMID: 31102202 Free PMC article.

9

Effectiveness and healthcare costs among stabilised rheumatoid arthritis patients with dose reduction of adalimumab or etanercept in real world.

Yang M, Galebach PJ, Signorovitch JE, Garg V. Yang M, et al. Among authors: garg v. Clin Exp Rheumatol. 2017 Sep-Oct;35(5):791-798. Epub 2017 Mar 23. Clin Exp Rheumatol. 2017. PMID: 28339358

10

Costs of Providing Infusion Therapy for Rheumatoid Arthritis in a Hospital-based Infusion Center Setting.

Schmier J, Ogden K, Nickman N, Halpern MT, Cifaldi M, Ganguli A, Bao Y, Garg V. Schmier J, et al. Among authors: garg v. Clin Ther. 2017 Aug;39(8):1600-1617. doi: 10.1016/j.clinthera.2017.06.007. Epub 2017 Jul 14. Clin Ther. 2017. PMID: 28716293 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,026 results

Search Page